The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment

March 14, 2023 updated by: Masaryk University

The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment - a Combined MRI and Non-invasive Brain Stimulation Study

Progressively causes the breakdown of cognitive functions and impairs quality of life for patients and their caregivers. In addition to memory impairment, visual attention is also compromised, even at the stage of mild cognitive impairment due to AD (MCI-AD). No treatment has been found for MCI-AD; therefore, attention has been drawn to non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), in order to enhance cognitive functions by modifying brain plasticity. In the current research, investigator aim to examine the long-term effects of the optimal multiple-session tDCS protocol in MCI-AD on visual attention including the transfer to an ecologically valid virtual environment and identify the neural underpinnings of tDCS-induced behavioral aftereffects using a combined tDCS/ MRI network-based approach.

Study Overview

Status

Completed

Detailed Description

Investigator will investigate the long-term effects of 10 active tDCS consecutive sessions using an optimized stimulation protocol as compared to a placebo stimulation on visual attention in the MCI-AD. A two-parallel-group, randomized, placebo-controlled design will be used. In addition, the cognitive transfer of tDCS will be evaluated. Repeated tDCS sessions will be performed in 10 consecutive sessions (2 weeks: Monday to Friday) over one preselected ROI together with ongoing visual attention training. During the stimulation, investigator will use the visual matching task. Before the repeated stimulation sessions, participants will undergo the neurocognitive examination. Behavioral examinations of the trained and untrained tasks (i.e. the transfer tasks) will be performed to assess the baseline performance. MRI protocol consisting of T1, T2, FLAIR, and fMRI during the task performance (visual matching task), resting state fMRI, and DTI sequences will be acquired before and after the whole 10-day stimulation protocol in order to search for active vs. placebo tDCS-induced changes in brain activation and resting state functional and structural connectivity and to identify neural correlates of behavioral changes. Behavioral assessment of the trained task and the transfer task will be repeated immediately after and again at a one-month follow-up visit after the end of the last stimulation session

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brno, Czechia, 61300
        • Ceitec, Masaryk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • amnestic single or multi-domain mild cognitive impairment patients in accordance with diagnostic criteria (Albert et al., 2011)

Exclusion Criteria:

  • psychiatric disorders, including major depression, major vascular lesions, and other brain pathologies detected by MRI that might present with cognitive decline
  • a cardio pacemaker or any MRI-incompatible metal in the body
  • epilepsy
  • any diagnosed psychiatric disorder
  • alcohol/drug abuse
  • lack of cooperation
  • presence of dementia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MCI patients with real transcranial direct current stimulation
Patients will receive 2mA stimulation in 10 consecutive sessions.
2mA stimulation for 20 minutes
Sham Comparator: MCI patients with sham transcranial direct current stimulation
Patients will receive sham stimulation in 10 consecutive sessions.
2mA stimulation for 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual-attention task accuracy
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Task will be presented on a computer and subject will respond by YES-NO buttons. Only if there are no differences in task accuracy, we will measure task reaction times (e.g. due to the roof effect).
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological assessment - z-score computed from multiple psychological domains
Time Frame: Change from baseline immediately after one month from completion of stimulation protocol
Z-scores based on neuropsychological assessment (lasting up to 40 min) evaluating (global cognitive functions, memory, attention, psychomotor functions, executive functions, visuospatial functions, language, depressive symptoms, and activities of daily living) Only if there are no changes in z-score, we will asses change on a level of individual tests.
Change from baseline immediately after one month from completion of stimulation protocol
Magnetic resonance imaging
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Investigator will record high resolution structural T1-weighted (MPRAGE) images, functional T2* weighted multiband EPI sequences, and DTI measurement. The total time spent in the scanner will be approximately 60 min
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Memory task in virtual reality performance - the accuracy
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Memory task in virtual reality performance - The time to accomplish different difficulty levels
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Memory task in virtual reality performance - The trajectories needed for completion of different difficulty levels
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Visual working memory task accuracy
Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol
Task will be presented on a computer and subject will respond by YES-NO buttons. Only if there are no differences in task accuracy, we will measure task reaction times (e.g. due to the roof effect).
Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lubomira Anderková, PhD, Ceitec, Masaryk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2020

Primary Completion (Actual)

October 30, 2022

Study Completion (Actual)

December 30, 2022

Study Registration Dates

First Submitted

May 10, 2019

First Submitted That Met QC Criteria

June 3, 2019

First Posted (Actual)

June 4, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on Transcranial Direct Current Stimulation (tDCS)

3
Subscribe